R&D productivity

News

AI helping us make smarter, faster decisions, says Novartis ...

Novartis is trialling artificial intelligence (AI) in settings across drug discovery and drug development to help its scientists improve decision making.

Views & Analysis

Will Gottlieb follow up on Trump's promise of a bonfire of regulations?

2016 saw slump in FDA drug approvals, but 2017 could be retu...

FDA approvals could rebound in 2017 - but concerns about big pharma R&D productivity won't go away.

News

FDA clears Viridian's Tepezza rival for thyroid eye disease

Viridian has fired a shot across Amgen's bows with the FDA approval of Tepezza rival Lumvoa in thyroid eye disease, a $2bn market.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

R&amp;D productivity

Editor's Picks